Cequa (Cyclosporine) Patent Expiration, LOE Window & CMS Spending

Cequa (Cyclosporine) by Sun Pharmaceutical: FDA Orange Book LOE 2037-02-28, 16 AB generics, $96.5M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSun Pharmaceutical
FDA Application & PathwayN210913 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2037-02-28
Orange Book Patents (*PED Extensions)5 patents (0 *PED)
Active AB-Rated Generic Competitors16
2024 CMS Total Public Spend$96.5M
2024 Medicare Part D Spend$76.6M
2024 Medicaid Spend$20.0M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 16.5% 2-yr change)